Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind study of SMP-986 in overactive bladder
jRCT2080221224Phase 2
- Sponsor
- Sumitomo Pharma
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in overactive bladder (OAB) comparing SMP-986 with Placebo (2 arms).
02
Drugs
Afacifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on jRCT2080221224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221224.